Company Analysis
Sign in

GH Research PLC (GHRS)

Nasdaq: GHRS · Pharmaceutical Preparations · Dublin 2, IE · filing with the SEC since 2021
Full chart Alerts Compare
Grade6.3
◀ Past 6.5● Present 6.2▶ Future 6.2
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedMar 5, 2026Feb 27, 2025Mar 7, 2024Mar 9, 2023Mar 28, 2022··
Research and development38,76535,01629,82120,4848,553338296
Selling, general and administrative21,95315,29611,40110,0706,54710814
General and administrative21,95315,29611,40110,0706,54710814
Total operating expenses60,71850,31241,22230,55415,100446310
Operating income-60,718-50,312-41,222-30,554-15,100-446-310
Finance costs463717723123r900
Finance income11,1289,8738,9781,16600·
Net finance income (costs)···922-90·
Income before income taxes-48,258-38,961-35,587-22,456-9,202-446-310
Income tax expense0000000
Net income-48,258-38,961-35,587-22,456-9,202-446-310
Net income to shareholders-48,258-38,961-35,587-22,456-9,202-446-310
Earnings per share, basic-0.79-0.75-0.68-0.43r-0.21r-0.016-0.011
Earnings per share, diluted-0.79-0.75-0.68-0.43r-0.21r-0.016-0.011
Weighted average shares, basic61,042,62152,028,14552,022,58852,020,84943,683,29628,359,36828,000,000
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextifrs-full:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyifrs-full:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfifrs-full:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherifrs-full:OperatingExpense
Operating income profit from running the business, before interest and taxifrs-full:ProfitLossFromOperatingActivities
Finance costs what its borrowing costifrs-full:FinanceCosts
Finance income what its cash and investments earnedifrs-full:FinanceIncome
Net finance income (costs) interest earned less interest paid, outside the businessifrs-full:FinanceIncomeCost
Income before income taxes profit before taxifrs-full:ProfitLossBeforeTax
Income tax expense tax charged on the period's profitifrs-full:IncomeTaxExpenseContinuingOperations
Net income the whole group's profit, minority holders' share includedifrs-full:ProfitLoss
Net income to shareholders the profit or loss that belongs to the company's shareholdersifrs-full:ProfitLossAttributableToOwnersOfParent
Earnings per share, basic net income per share outstandingifrs-full:BasicEarningsLossPerShare
Earnings per share, diluted net income per share, counting every share that could be issuedifrs-full:DilutedEarningsLossPerShare
Weighted average shares, basic the average count of shares outstandingifrs-full:WeightedAverageShares
SI Assistanton GHRS · research, not advice